WallStSmart

Goodrx Holdings Inc (GDRX)vsVeeva Systems Inc Class A (VEEV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Veeva Systems Inc Class A generates 321% more annual revenue ($3.32B vs $787.89M). VEEV leads profitability with a 28.4% profit margin vs 2.6%. VEEV trades at a lower P/E of 34.6x. VEEV earns a higher WallStSmart Score of 69/100 (B-).

GDRX

Avoid

35

out of 100

Grade: F

Growth: 2.7Profit: 5.0Value: 4.7Quality: 4.5
Piotroski: 4/9Altman Z: 0.20

VEEV

Strong Buy

69

out of 100

Grade: B-

Growth: 7.3Profit: 8.0Value: 7.3Quality: 9.0
Piotroski: 4/9Altman Z: 4.78
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GDRX.

VEEVUndervalued (+38.9%)

Margin of Safety

+38.9%

Fair Value

$289.59

Current Price

$207.91

$81.68 discount

UndervaluedFair: $289.59Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GDRX1 strengths · Avg: 8.0/10
Price/BookValuation
1.8x8/10

Reasonable price relative to book value

VEEV6 strengths · Avg: 9.2/10
Operating MarginProfitability
30.9%10/10

Strong operational efficiency at 30.9%

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.7810/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

PEG RatioValuation
0.888/10

Growing faster than its price suggests

Revenue GrowthGrowth
16.3%8/10

16.3% revenue growth

Areas to Watch

GDRX4 concerns · Avg: 2.8/10
Market CapQuality
$1.00B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.3%3/10

ROE of 3.3% — below average capital efficiency

Profit MarginProfitability
2.6%3/10

2.6% margin — thin

P/E RatioValuation
49.3x2/10

Premium valuation, high expectations priced in

VEEV1 concerns · Avg: 4.0/10
P/E RatioValuation
34.6x4/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : GDRX

The strongest argument for GDRX centers on Price/Book.

Bull Case : VEEV

The strongest argument for VEEV centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 28.4% and operating margin at 30.9%. Revenue growth of 16.3% demonstrates continued momentum.

Bear Case : GDRX

The primary concerns for GDRX are Market Cap, Return on Equity, Profit Margin. A P/E of 49.3x leaves little room for execution misses. Thin 2.6% margins leave little buffer for downturns.

Bear Case : VEEV

The primary concerns for VEEV are P/E Ratio.

Key Dynamics to Monitor

GDRX profiles as a value stock while VEEV is a growth play — different risk/reward profiles.

GDRX carries more volatility with a beta of 1.61 — expect wider price swings.

VEEV is growing revenue faster at 16.3% — sustainability is the question.

VEEV generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

VEEV scores higher overall (69/100 vs 35/100), backed by strong 28.4% margins and 16.3% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Goodrx Holdings Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

GoodRx Holdings, Inc. provides information and tools that allow consumers to compare prices and save when buying prescription drugs in the United States. The company is headquartered in Santa Monica, California.

Visit Website →

Veeva Systems Inc Class A

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.

Visit Website →

Want to dig deeper into these stocks?